AstraZenecas

Britain should follow the US and approve AstraZeneca's breakthrough drug to stop hundreds of thousands of vulnerable adults from becoming ill in the oncoming Omicron wave, experts said today. The antibody cocktail, called Evusheld, was…

Europe may be suffering a ferocious fourth wave of Covid hospital admissions because it delayed rolling out the AstraZeneca vaccine to older people, the boss of the pharmaceutical giant suggested today.Pascal Soriot, chief executive at…

AstraZeneca on Thursday (Nov 18) cemented its lead in bringing a preventative COVID-19 shot for the non-infected to market for people who do not respond well to vaccines, saying its antibody drug cocktail offered 83 per cent protection over…

AstraZeneca says its cocktail of antibodies, AZD7442, has given results deemed positive against Covid-19 during phase III clinical trials.Gerard Bottino | SOPA Images | LightRocket | Getty ImagesAstraZeneca's antibody treatment has been…

By Staff The Canadian Press Posted November 3, 2021 11:55 am …

Britain will donate another 20million doses of AstraZeneca's coronavirus vaccine to poorer countries, No10 announced today.Half of the surplus supply has already been shipped, while the remaining batch will be sent in the next few weeks. …

PARIS: Valneva SE on Monday (Oct 18) said its experimental COVID-19 vaccine demonstrated efficacy "at least as good, if not better" than AstraZeneca's shot in a late-stage trial comparing the two, with significantly fewer adverse side…

Britons vaccinated with the AstraZeneca jab will be allowed into the US when travel restrictions are eased this autumn, America's top Covid doctor suggested today. Dr Anthony Fauci said he did not see 'any reason' why people given the…

AstraZeneca's Covid vaccine may trigger a nerve disorder in 'very rare' cases, according to the EU's vaccine watchdog.The European Medicines Agency said today 833 cases of Guillain-Barre syndrome had been reported worldwide out of…

AstraZeneca's new antibody therapy reduced the risk of people developing COVID-19 symptoms by 77 per cent in a late-stage trial, putting the drugmaker on track to offer protection to those who respond poorly to vaccines. The company said…